Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study

被引：0
|
作者：
Kapoor, R. [1 ]
Sellebjerg, F. [2 ]
Hartung, H. -P. [3 ]
Arnold, D. L. [4 ]
Freedman, M. S. [5 ]
Jeffery, D. [6 ]
Miller, A. [7 ]
Edwards, K. R. [8 ]
Singh, C. M. [9 ]
Chang, I. [9 ]
Ren, Z. [9 ]
Sangurdekar, D. [9 ]
Zhu, B. [9 ]
Sheikh, S. [9 ]
Mehta, D. [9 ]
Ho, P. -R. [9 ]
Campbell, N. [9 ]
Edwards, M. [9 ]
Fisher, E. [9 ]
Kieseier, B. C. [9 ]
Rudick, R. A. [9 ]
Plavina, T. [9 ]
机构：
[1] UCL Inst Neurol, London, England
[2] Univ Copenhagen, Danish Multiple Sclerosis Ctr, Rigshosp, Copenhagen, Denmark
[3] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany
[4] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[5] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[6] Piedmont HealthCare, Mooresville, NC USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[8] MS Ctr Northeastern New York, Latham, NY USA
[9] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1740
引用
收藏
页码：988 / 988
页数：1
相关论文
共 50 条
  • [41] Evaluation of neurofilament heavy chain levels in progressive multiple sclerosis patients: preliminary results
    Kaymakamzade, B.
    Kurne, A. Tuncer
    Tumani, H.
    Lehmensiek, V.
    Sayat, G.
    Karabudak, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 697 - 697
  • [42] ASCEND Phase 3 Trial Open-Label Extension Study Results: Natalizumab May Delay Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS)
    Hartung, Hans-Peter
    Arnold, Douglas
    Freedman, Mark
    Havrdova, Eva
    Jeffery, Douglas
    Kapoor, Raju
    Miller, Aaron
    Sellebjerg, Finn
    Li, Haihong
    Lucas, Nisha
    Cadavid, Diego
    Campbell, Nolan
    Ho, Pei-Ran
    Steiner, Deborah
    NEUROLOGY, 2017, 88
  • [43] Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures
    Gaetani, Lorenzo
    Schoonheim, Menno M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1831 - 1833
  • [44] Temporal variability profile of serum neurofilament light levels in multiple sclerosis patients
    Calabresi, P. A.
    Arnold, D. A.
    Sangurdekar, D.
    Singh, C. M.
    De Moor, C.
    Engle, B.
    Goyal, J.
    Deykin, A.
    Fisher, E.
    Kieseier, B. C.
    Rudick, R. A.
    Plavina, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 24 - 25
  • [45] Basal levels of serum neurofilament light in normal aging and multiple sclerosis patients
    Gasque Rubio, R.
    Villar, L. M.
    Cubas Nunez, L.
    Laiz, B.
    Quintanilla Bordas, C.
    Carratala Bosca, S.
    Gil-Perotin, S.
    Perez Miralles, F.
    Alcala, C.
    Castillo Villalba, J.
    Casanova Estruch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 525 - 525
  • [46] Serum neurofilament light chain as a presymptomatic biomarker in multiple sclerosis
    Bjornevik, K.
    Munger, K. L.
    Cortese, M.
    Barro, C.
    Healy, B. C.
    Niebuhr, D. W.
    Scher, A. I.
    Kuhle, J.
    Ascherio, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 108 - 109
  • [47] Neurofilament light chain in the assessment of patients with multiple sclerosis
    Domingues, Renan Barros
    Peres Fernandes, Gustavo Bruniera
    Vilela de Moura Leite, Fernando Brunale
    Senne, Carlos
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2019, 77 (06) : 436 - 441
  • [48] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity, Progression and Treatment Response in Patients with Multiple Sclerosis
    Fabis-Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Sue
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP2 - NP2
  • [49] Serum neurofilament light chain levels are increased at the onset of PML in natalizumab-treated MS patients
    Dalla Costa, G.
    Martinelli, V.
    Moiola, L.
    Sangalli, F.
    Colombo, B.
    Finardi, A.
    Cinque, P.
    Kolb, E. -M.
    Haghikia, A.
    Gold, R.
    Furlan, R.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 327 - 327
  • [50] Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis
    Buchmann, A.
    Pirpamer, L.
    Pinter, D.
    Voortman, M.
    Helmlinger, B.
    Pichler, A.
    Bachmaier, G.
    Ropele, S.
    Enzinger, C.
    Khalil, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 192 - 193
12345